IDEAYA Biosciences Files New Shelf Registration for $156.6M ATM Offering

IDEAYA Biosciences, Inc. filed a new automatic shelf registration statement on May 5, 2026, to replace its expiring prior registration statement. This action allows the company to continue its "at-the-market" (ATM) equity offering program. Under the existing Sales Agreement with Jefferies LLC, the company can offer and sell common stock with aggregate gross proceeds of up to $156.6 million, representing the remaining capacity available. The company had previously sold over $193.4 million in common stock under the prior registration statement.